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Abstract
Urachal carcinoma is a rare neoplasm, which accounts for only 0.5–2% of bladder malignancies, and arises
from a remnant of the fetal genitourinary tract. A 46-year-old woman presented with a history of pelvic
pain and frequent daytime urination. Ultrasound (US), computed tomography (CT), and magnetic resonance
(MR) demonstrated a supravesical heterogeneous mass with calcifications. The patient underwent a
partial cystectomy with en-bloc resection of the mass and histopathological examination revealed the
diagnosis of urachal adenocarcinoma. Urachal carcinomas are usually associated with poor prognosis
and early diagnosis is fundamental. CT and MR are useful to correctly diagnose and preoperatively staging.
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The urachus is an embryological remnant of urogenital
sinus and allantois that usually involutes before birth and
remains as the median umbilical ligament. Pathogenesis of
urachal carcinoma is not fully understood. The prognosis
is generally poor, because these tumors often are diagnosed
late in the course of the disease and consequently the
majority present with local invasion or metastatic disease.
Although there are no specific imaging findings of urachal
carcinomas, the most characteristic imaging feature is a
midline supravesical mass with low-attenuation component
and calcifications reflecting the mucin content. CT and MR
also provide important information about the local exten-
sion of the tumor and distant metastases. Surgery is the
mainstay of therapy. We report a case of primary adenocar-
cinoma of the urachus and describe and illustrate US, CT,
and MR imaging findings.
Case report
A 46-year-old woman presented at our hospital with recur-
rent pelvic pain and frequent daytime urination of three
months duration. Her medical history was unremarkable.
Despite suprapubic tenderness on palpation, physical
examination was normal.
Complete blood count revealed marked increase in
CEA to 1603 ng/mL (reference value ,4 ng/mL) and
slight increase in CA 125 to 46.5 U/mL (reference value
,35 U/mL).
Pelvic ultrasound revealed a supravesical complex cystic
mass with foci of increased echogenicity, suggestive of cal-
cifications (Fig. 1).
On contrast-enhanced CT it was seen a heterogeneous
mass, of approximately 12.5 cm, extending through the
anterosuperior wall of the bladder to the right flank. The
lesion revealed low-attenuation and multiple dystrophic cal-
cifications, suggestive of mucinous adenocarcioma. There
was no evidence of local or distant metastases (Fig. 2).
Fig. 1 Pelvic ultrasonography revealed a large complex cystic mass with cal-
cifications (arrow) located superiorly to the bladder ()
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MR was performed to better characterize the lesion
and revealed a large inhomogeneous mass in contact
with the dome and superior wall of the bladder and
occupying the right flank. The lesion showed high
signal intensity on T2-weighted images and intermediate
signal on T1-weighted images. After intravenous contrast
Fig. 3 MR revealed an inhomogeneous mass with intermediate signal intensity on T1-weighted images (a) and high signal intensity on T2-weighted images (b).
After the administration of gadolinium (c), the mass enhanced slightly peripherally and on solid vegetations ()
Fig. 2 On axial contrast-enhanced CT scan (a) was seen a large heterogeneous solid mass, with areas of low attenuation and dystrophic calcifications, sugges-
tive of mucin content. Coronal (b) and sagittal (c) reformatted CT images, revealed the mass located superior to the bladder and extending through the right flank.
The lesion contact the bladder but no focal thickening of the bladder wall was evident
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administration the mass enhanced slightly peripherally
(Fig. 3).
Open laparotomy revealed that the lesion was strongly
adhered to the wall of the bladder and partial cystectomy
with en-bloc resection of the mass was performed.
Histologic analysis revealed an urachal mucinous
adenocarcinoma.
Discussion
The urachus is an embryologic remnant of the fetal geni-
tourinary tract seen as a tubular structure extending in the
midline between the dome of the bladder and the umbilicus
that usually involutes before birth and remains in adults as
the median umbilical ligament.
Primary adenocarcinomas of the urachus are extremely
rare, representing only 0.5–2% of all bladder malignancies,
although 34% of bladder adenocarcinomas are urachal in
origin (1). It is believed to arise from malignant transform-
ation of columnar or glandular metaplastic epithelium and
mucin production is found in up to 75% of cases on histo-
logical analysis.
Urachal carcinomas mainly affect patients between 40 and
70 years old and have a male predilection (2). These tumors
can be silent because of their extraperitoneal location, and
consequently usually presents at an advanced stage, and
often shows local invasion or metastases to the pelvic
lymph nodes, lung, brain, liver, or bone. Hematuria,
dysuria, abdominal pain, and umbilical discharge are the
most frequent symptoms.
The diagnostic evaluation for urachal carcinoma should
include a careful history and physical examination. A
urine analysis with cytology may be helpful.
Although carcinoma of the urachus can occur in any site
along the urachal tract, the most common locations are the
dome of the bladder and the umbilicus.
US may demonstrate a supravesical complex cystic mass.
CT or MR confirm the US findings and provide more infor-
mation about local extent of the disease, pelvic lymph-node
involvement, and systemic metastases. On CT urachal
carcinoma is usually seen as a midline mass anterosuperior
to the dome of the bladder that can be solid, cystic, or
mixed. In 60% of cases low-attenuation components are
seen, representing mucin content. Like other mucinous ade-
nocarcinomas, urachal carcinomas may produce calcifica-
tions, which may occur in 50–70% of cases and are
considered nearly pathognomonic for urachal adenocarci-
noma (1, 3). On MR imaging a mass with increased signal
intensity is usually seen on T2-weighted images because
of the presence of mucin within the tumor (4).
The radiologic differential diagnosis includes benign
urachal tumors that may mimic malignancy, like adenomas,
fibromas, fibromyomas, and hamartomas, infected urachal
remnants, and other malignant tumors like adenocarcino-
mas of non-urachal origin, transitional cell carcinomas,
and metastases originating from primary lesions of the
colon, prostate, or female genital tract (1, 5).
Primary treatment of localized disease includes wide local
excision of the urachus, umbilicus, and surrounding soft
tissue combined with partial or radical cystectomy and
bilateral pelvic lymphadenectomy (6).
A cystoscopy is necessary to evaluate whether the carci-
noma has penetrated the urothelium of the bladder and a
transurethral biopsy should be performed if possible.
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